Class 2 recall-Labetalol 200mg tablets

Tillomed Laboratories Limited is recalling one batch of Labetalol 200mg Tablets as a precautionary measure due to potential mix-up at the manufacturing site.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-tillomed-laboratories-limited-labetalol-200mg-tablets-el-24-a-slash-52?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2e33e9ba-323e-48e8-a188-eb6c601fda3b&utm_content=immediately

Further Information

For all medical enquiries, please contact Tillomed Laboratories Limited by email at either medical.information@tillomed.co.uk or PVUK@tillomed.co.uk, or telephone 0800 9706115.

For enquiries relating to stock returns please email Tillomed Laboratories Limited customer services customer.service@tillomed.com or telephone 01480 402 400.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Parasolve 500mg

Kent Pharma UK has identified an error in the Patient Information Leaflet (PIL) for Paracetamol 500mg Effervescent Tablets.

MHRA Drug alert date: 28th October 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-kent-pharma-uk-parasolve-paracetamol-500mg-effervescent-tablets-el-24-a-slash-51?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=5872b8d6-4416-46db-b971-7547e5419b92&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact medical@kent-athlone.com

For stock control enquiries please contact customer.service@kent-athlone.com

Class 2 recall-Phenobarbital tabs 15mg Bristol

Bristol Laboratories Ltd. are recalling one batch of Phenobarbital Bristol Labs 15mg Tablets as a precautionary measure due to the potential of contamination of small metallic particles within the tablets.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-bristol-laboratories-ltd-phenobarbital-bristol-labs-15mg-tablets-el-24-a-slash-50?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=7ae4cb12-a098-4a7b-84d5-cf21de226896&utm_content=immediately

Further Information

For medical information enquiries please contact: Notifications@bristol-labs.co.uk

For stock control enquiries please contact: Notifications@bristol-labs.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Paracetamol 500mg effervescent tablets Kent Pharma

Kent Pharma UK has identified an error in the Patient Information Leaflet (PIL) for Paracetamol 500mg Effervescent Tablets.

MHRA Drug alert date: 21st October 2024

MHRA drug alert linkhttps://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-kent-pharma-uk-paracetamol-500mg-effervescent-tablets-el-24-a-slash-49?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=5a1672aa-08cf-4721-b0cb-ba1f21ce6982&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact medical@kent-athlone.com

For stock control enquiries please contact customer.service@kent-athlone.com

Class 4 caution in use-Linezolid 600mg tablets

Sandoz Ltd. has informed the MHRA that there is missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for Linezolid 600 mg film-coated tablets.

MHRA Drug alert date: 10th October 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-sandoz-ltd-dot-linezolid-600-mg-film-coated-tablets-el-24-a-slash-48?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=025d6ab9-9885-40e6-ab69-13bedf8bcd94&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information queries, please contact: sandozgb@EU.propharmagroup.com, Telephone: +44 1276 698 101.

For stock control queries, please contact: sales.sandoz-gb@sandoz.com, Telephone: +44 1276 698607.

Class 3 recall-Trandolapril 2mg and 4mg Capsules Mylan

Generics (UK) Ltd T/A Mylan UK is recalling specific batches of trandolapril after re-testing showed out of specification results.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-viatris-uk-healthcare-ltd-trandolapril-2mg-and-4mg-capsules-el-24-a-slash-47?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=089c0476-44ad-4de3-95eb-d62d62b8c195&utm_content=immediately

Further Information

For medical information enquiries please contact Viatris UK Healthcare Limited Medical Information at +44 (0)1707 853 000 (select option 1) or info.uk@viatris.com.

For stock control enquiries please contact Customer Services at +44 (0)1707 853 000 (select option 2).

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall- Cyanocobalamin 50mcg tablets (Glenmark Livery

Glenmark Pharmaceuticals Europe Ltd is recalling the affected batches as a precautionary measure due to out of specification results for unknown impurities during routine stability testing and additional re-testing.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-glenmark-pharmaceuticals-europe-ltd-cyanocobalamin-50-mcg-tablets-el-24-a-slash-46?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=856d3399-61cb-46ab-badf-8fa8c84a1e83&utm_content=immediately

Further Information

For medical information enquiries please use the following options by phone +44 8004 580 383 or email medical_information@glenmarkpharma.com.

For stock control enquiries please email orders.uk@glenmarkpharma.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Rosuvastatin 20mg & 40mg Sandoz

Sandoz Ltd. has informed the MHRA that there is missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for Rosuvastatin 20mg and 40mg Tablets.

MHRA Drug alert date: 1st October 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-sandoz-ltd-dot-rosuvastatin-20mg-40mg-tablets-el-24-a-slash-45

This is a caution in use only we are not accepting stock returns

Further Information

For medical information queries, please contact: sandozgb@EU.propharmagroup.com, Telephone: +44 1276 698 101.

For stock control queries, please contact: sales.sandoz-gb@sandoz.com, Telephone: +44 1276 698607.

Class 4 caution in use-Risperidone 1mg, 2mg & 3mg tablets

Sandoz Ltd. has informed the MHRA that there is missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for Risperidone 1mg, 2mg and 3mg and Tablets.

MHRA Drug alert date: 26th September 2024

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-sandoz-ltd-dot-risperidone-1mg-2mg-3mg-tablets-el-24-a-slash-43?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=b4d60715-056e-4313-977a-7a57a225af0e&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information queries, please contact: sandozgb@EU.propharmagroup.com, Telephone: +44 1276 698 101.

For stock control queries, please contact: sales.sandoz-gb@sandoz.com, Telephone: +44 1276 698607.

Field safety notice-Lacri-lube eye ointment

We have received a field safety notice from Abbvie Ltd on two batches of Lacri-lube

Date of recall:19/09/24

Reason: The impacted lots may contain a breach in the tube seal

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.